What's breaking now, across thousands of outlets.
This week at Ben-Gurion Airport: An Israeli physiotherapist who's spent 14 years in Berlin but still wonders if it's time to come home, and a Russian teenager whose marriage to an Israeli has her living between two worlds
We haven't written up this one. Haaretz has the full story — the link below goes straight to it.
For the pharmaceutical division, US approval is crucial: its bestseller Xarelto is losing sales. Asundexian is intended to fill the gap - especially in the US, where Bayer is growing the fastest.
A pooled analysis of the studies found that about two-thirds of participants receiving the drug retatrutide experienced at least a 50% reduction in knee pain, compared with 38% of those receiving a…
South Africa is stepping up Ebola screening at ports of entry, preparing 36 hospitals and introducing a travel questionnaire as the Bundibugyo outbreak continues in the DRC.
"Brilliant, analytically rigorous, prolific, passionate about improving the way we generate and apply medical evidence, with intellectual sharpness and a relentless drive to improve science." The post…
